GKB Ophthalmics

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE265D01015
  • NSEID: GKB
  • BSEID: 533212
INR
56.00
3.01 (5.68%)
BSENSE

Feb 11

BSE+NSE Vol: 95

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 360373,
    "name": "GKB Ophthalmics",
    "stock_name": "GKB Ophthalmics",
    "full_name": "GKB Ophthalmics Ltd",
    "name_url": "stocks-analysis/gkb-ophthalmics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "56.00",
    "chg": 3.01,
    "chgp": "5.68%",
    "dir": 1,
    "prev_price": "52.99",
    "mcapval": "28.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533212,
    "symbol": "GKB",
    "ind_name": "Healthcare Services",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE265D01015",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "95 ",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gkb-ophthalmics-360373-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "GKB Ophthalmics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-ltd-is-rated-strong-sell-3771229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GKBOphthalmicsL_mojoScore_3771229.png",
        "date": "2025-12-26 15:12:03",
        "description": "GKB Ophthalmics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 10 December 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 26 December 2025, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "GKB Ophthalmics Sees Revision in Market Assessment Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gkb-ophthalmics-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3750673",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GKBOphthalmics_mojoScore_3750673.png",
        "date": "2025-12-08 10:10:22",
        "description": "GKB Ophthalmics has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. The healthcare services company’s assessment now indicates heightened caution among investors, driven by a combination of fundamental and market performance factors."
      },
      {
        "title": "GKB Ophthalmics Falls to 52-Week Low of Rs.47 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-stock-falls-to-52-week-low-of-rs47-amidst-continued-downtrend-3748833",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GKBOphthalmics_priceRelatedfactors_3748833.png",
        "date": "2025-12-05 11:24:45",
        "description": "GKB Ophthalmics has reached a new 52-week low of Rs.47, marking a significant decline amid a sustained period of negative returns. The stock has been on a downward trajectory for six consecutive trading sessions, reflecting ongoing pressures within the healthcare services sector."
      },
      {
        "title": "GKB Ophthalmics Falls to 52-Week Low of Rs.47.26 Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-stock-hits-52-week-low-amidst-continued-downtrend-3746968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GKBOphthalmics_priceRelatedfactors_3746968.png",
        "date": "2025-12-04 15:43:54",
        "description": "GKB Ophthalmics has reached a fresh 52-week low of Rs.47.26 today, marking a significant milestone in its ongoing decline. The stock has experienced a sustained downward trajectory over the past week, reflecting a series of financial and market factors that have weighed on its performance."
      },
      {
        "title": "GKB Ophthalmics Stock Falls to 52-Week Low of Rs.53 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-stock-hits-52-week-low-amidst-continued-underperformance-3743742",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GKBOphthalmics_priceRelatedfactors_3743742.png",
        "date": "2025-12-03 10:20:13",
        "description": "GKB Ophthalmics has reached a new 52-week low of Rs.53, marking a significant decline in its stock price over the past year. This level reflects ongoing challenges faced by the company within the healthcare services sector, as it continues to trade below key moving averages and underperform relative to broader market indices."
      },
      {
        "title": "GKB Ophthalmics Stock Falls to 52-Week Low of Rs.54 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-stock-hits-52-week-low-at-rs-54-amidst-continued-downtrend-3741790",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GKBOphthalmics_priceRelatedfactors_3741790.png",
        "date": "2025-12-02 12:42:53",
        "description": "GKB Ophthalmics has reached a new 52-week low of Rs.54 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the healthcare services segment."
      },
      {
        "title": "GKB Ophthalmics Falls to 52-Week Low of Rs.56 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-stock-falls-to-52-week-low-of-rs56-amidst-continued-underperformance-3724606",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GKBOphthalmics_priceRelatedfactors_3724606.png",
        "date": "2025-11-24 10:32:54",
        "description": "GKB Ophthalmics has reached a new 52-week low of Rs.56 today, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock’s subdued performance over the past year, contrasting sharply with broader market gains."
      },
      {
        "title": "GKB Ophthalmics Stock Falls to 52-Week Low of Rs.56 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-stock-hits-52-week-low-amidst-continued-underperformance-3724604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GKBOphthalmics_priceRelatedfactors_3724604.png",
        "date": "2025-11-24 10:32:53",
        "description": "GKB Ophthalmics touched a fresh 52-week low of Rs.56 today, marking a significant decline in its share price over the past year. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing challenges within the company’s financial metrics and valuation."
      },
      {
        "title": "GKB Ophthalmics Stock Falls to 52-Week Low of Rs.56 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gkb-ophthalmics-stock-hits-52-week-low-amidst-continued-underperformance-3724601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GKBOphthalmics_priceRelatedfactors_3724601.png",
        "date": "2025-11-24 10:32:48",
        "description": "GKB Ophthalmics has reached a new 52-week low of Rs.56, marking a significant decline in its stock price amid ongoing challenges in financial performance and market positioning within the healthcare services sector."
      }
    ],
    "total": 64,
    "sid": "360373",
    "stock_news_url": "https://www.marketsmojo.com/news/gkb-ophthalmics-360373"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "30-Jan-2026",
      "details": "GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Inside Trading Window) Regulations 2015 had been closed from January 01 2026 will now re-open after the completion of 48 hours from the date of submission of Financial results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Intimation On Conversion Of Statutory Auditors Firm Into LLP- MSKA & Associates To MSKA & Associates LLP Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.",
      "datetime": "20-Jan-2026",
      "details": "We would like to inform you that the Statutory Auditors of the Company MSKA & Associates Chartered Accountants have intimated the Company that the Firm has converted itself into a Limited Liability Partnership (LLP) under the provision of the Limited Liability Partnership Act 2008 and is now known as MKS & Associates LLP Chartered Accountants. The will continue to function and discharge their obligations as Auditors for the remaining period of the tenure of appointment as statutory Auditors. This is for your information an records.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Jan-2026",
      "details": "Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended December 31 2025. Kindly acknowledge receipt of the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "GKB Ophthalmics Ltd has declared <strong>12%</strong> dividend, ex-date: 21 Sep 10",
          "dt": "2010-09-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.

30-Jan-2026 | Source : BSE

GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Inside Trading Window) Regulations 2015 had been closed from January 01 2026 will now re-open after the completion of 48 hours from the date of submission of Financial results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.

Intimation On Conversion Of Statutory Auditors Firm Into LLP- MSKA & Associates To MSKA & Associates LLP Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.

20-Jan-2026 | Source : BSE

We would like to inform you that the Statutory Auditors of the Company MSKA & Associates Chartered Accountants have intimated the Company that the Firm has converted itself into a Limited Liability Partnership (LLP) under the provision of the Limited Liability Partnership Act 2008 and is now known as MKS & Associates LLP Chartered Accountants. The will continue to function and discharge their obligations as Auditors for the remaining period of the tenure of appointment as statutory Auditors. This is for your information an records.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Jan-2026 | Source : BSE

Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended December 31 2025. Kindly acknowledge receipt of the same.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

12 Feb 2026

stock-summary
DIVIDEND

GKB Ophthalmics Ltd has declared 12% dividend, ex-date: 21 Sep 10

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available